Ads
-
Related paper
- Changes in Extracellular Matrix Components Metabolism in Patients with Nonalcoholic Steatohepatitis on the Background of Obesity and Comorbidity with Chronic Kidney Disease
- Optimization of Treating Nonalcoholic Steatohepatitis with Obesity and Chronic Kidney Disease of the I-II Stages
- The Influence of Pathogenetic Treatment on Peroxidation in Patients with Ischemic Heart Disease and Comorbid Nonalcoholic Steatohepatitis
- Methicillin-resistant staphylococcus aureus carriage and comorbidity in patients with chronic kidney disease V D stage: a 3-year prospective study
- Role of 2-D echocardiography in detecting cardiovascular abnormalities in chronic kidney disease patients: Case series of 50 chronic kidney disease patients
- Can body shape index indicate obesity-associated inflammation and cardiovascular diseases in stage 3-4 chronic kidney disease patients?
- Factors related to the progression of Chronic Kidney Disease after two years of follow-up of stage 3 Chronic kidney Disease Patients
- Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis
- INFLUENCE OF URSODEOXY-CHOLIC ACID ON CLINICAL COURSE OF CHRONIC NON-CALCULOUS CHOLECYSTITIS ON THE BACKGROUND OF NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME
- COMORBIDITY AND SURVIVAL OF PATIENTS WITH CHRONIC KIDNEY DISEAS STAGE 5 D